Genetic alterations involved in initiation and progression of human pancreatic cancer
基因改变参与人类胰腺癌的发生和进展
基本信息
- 批准号:09470049
- 负责人:
- 金额:$ 8万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:1997
- 资助国家:日本
- 起止时间:1997 至 1999
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
1.We previously identified frequently deleted region in human pancreatic cancer in chromosome arms 1p, 6q, 9p, 12q, 17p, and 18q. Among these regions, losses of 12q, 17p, and 18q were found to associated with poor prognosis in human pancreatic cancer. 17p and 18q are the loci for TP53 and SMAD4, respectively.2.On 6q and 12q, three and two smallest regions of overlap (SROs), respectively, were identified. BAC contigs for one region on 6q and two regions on 12q were constructed, and some genes in these regions were analyzed.3.DUSP6 on 12q21 and TDG on 12q24 were analyzed. Although no genomic alterations were found, loss or suppressed expression in pancreatic cancer cell lines were observed, suggesting the involvement of suppressed expression of these genes in human pancreatic carcinogenesis.4.Adenoviral mediated delivery of the SMAD4 gene in pancreatic cancer cell lines with homozygous deletion of SMAD4 did not show any suppression of cell growth. We think that inactivation of the SMAD4 gene is not associated with acceleration of cell growth but associated with some other mechanisms in pancreatic carcinogenesis.5.We reported that loss of 18q is an early event in pancreatic carcinogenesis. There is a possibility that mutation of the SMAD4 gene is responsible for the initial step of pancreatic carcinogenesis as well as prognosis defining factor. However, there is a possibility of unknown tumor suppressor gene on 18q that is distinct from SMAD4.
1.我们以前在人胰腺癌染色体1p、6q、9p、12q、17p和18q上发现了常见的缺失区域。在这些区域中,发现12q、17p和18q的丢失与人类胰腺癌的预后不良相关。17p和18q分别是TP53和SMAD 4的基因座。2.在6q和12q上分别鉴定出3个和2个最小重叠区(SROs)。构建6q上一个区域和12q上两个区域的BAC重叠群,并对这些区域的部分基因进行分析。3.对12q21上的DUSP6和12q24上的TDG进行分析。虽然没有发现基因组改变,但在胰腺癌细胞系中观察到这些基因的缺失或表达抑制,表明这些基因的表达抑制参与了人胰腺癌的发生。4.腺病毒介导的SMAD 4基因在SMAD 4纯合缺失的胰腺癌细胞系中的递送没有显示任何细胞生长抑制。我们认为SMAD 4基因的失活与胰腺癌发生的细胞生长加速无关,但与胰腺癌发生的其他机制有关。5.我们报道了18 q缺失是胰腺癌发生的早期事件。SMAD 4基因突变可能是胰腺癌发生的起始步骤,也可能是决定预后的因素。然而,在18 q上存在与SMAD4不同的未知肿瘤抑制基因的可能性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Cloning and characterization of the human UDP-N-acetylglucosamine:a-1,3-D-mannosideb-1,4-N-acetylglucosaminyltransferase IV-homologue (hGnT-IV-H) gene.
人 UDP-N-乙酰氨基葡萄糖:a-1,3-D-甘露糖苷b-1,4-N-乙酰氨基葡萄糖转移酶 IV 同源物 (hGnT-IV-H) 基因的克隆和表征。
- DOI:
- 发表时间:1999
- 期刊:
- 影响因子:0
- 作者:Furukawa;T.;Youssef;E.M.;Yatsuoka;T.;Yokoyama;T.;Makino;N.;Inoue;H.;Fukushige;S.;Hoshi;M.;Hayashi;Y.;Sunamura;M.;Horii;A.
- 通讯作者:A.
The insulin-like growth factor II receptor gene is mutated in genetically unstable cancers of the endometrium, stomach, and colorectum.
- DOI:
- 发表时间:1997-05
- 期刊:
- 影响因子:11.2
- 作者:O. Hong;H. Shiwaku;H. Hagiwara;K. Miura;T. Abe;Y. Kato;H. Ohtani;K. Shiiba;R. Souza;S. Meltzer;A. Horii
- 通讯作者:O. Hong;H. Shiwaku;H. Hagiwara;K. Miura;T. Abe;Y. Kato;H. Ohtani;K. Shiiba;R. Souza;S. Meltzer;A. Horii
Genomic analysis of DUSP6, a dual specificity MAP kinase phosphatase, in pancreatic cancer
- DOI:10.1159/000015091
- 发表时间:1998-01-01
- 期刊:
- 影响因子:0
- 作者:Furukawa, T;Yatsuoka, T;Horii, A
- 通讯作者:Horii, A
Abe,T.: "Identification of three commonly deleted regions on chromosome arm 6q in human pancreatic cancer." Genes,Chromosomes & Cancer. (in press).
Abe,T.:“人类胰腺癌染色体臂 6q 上三个常见缺失区域的鉴定。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Yatsuoka,T.: "Genomic analysis of the thymine-DNA glycosylase(TDG)gene on 12q22-q24.1 in human pancreatic ductal adenocarcinoma." International Journal of Pancreatology. (in press).
Yatsuoka,T.:“对人胰腺导管腺癌 12q22-q24.1 上的胸腺嘧啶 DNA 糖基化酶 (TDG) 基因进行基因组分析。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HORII Akira其他文献
HORII Akira的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HORII Akira', 18)}}的其他基金
Development of invasion and/or metastasis of pancreatic and lung cancers by controlling S100A4
通过控制S100A4促进胰腺癌和肺癌的侵袭和/或转移
- 批准号:
23590452 - 财政年份:2011
- 资助金额:
$ 8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of a novel tumor suppressor gene on chromosome arm 18q in human pancreatic caner
人胰腺癌染色体臂 18q 上新型抑癌基因的鉴定
- 批准号:
18390118 - 财政年份:2006
- 资助金额:
$ 8万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
New avenue for molecular diagnosis of pancreatic and gynecological cancers
胰腺癌和妇科癌症分子诊断的新途径
- 批准号:
17015003 - 财政年份:2005
- 资助金额:
$ 8万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
Reseearch on Genetic Alterations in the Development and Progression of Human Pancreatic Cancer
人类胰腺癌发生发展中的基因改变研究
- 批准号:
12470043 - 财政年份:2000
- 资助金额:
$ 8万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Genetic alterations involved in initiation and progression of human cancer
基因改变参与人类癌症的发生和进展
- 批准号:
07272204 - 财政年份:1999
- 资助金额:
$ 8万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
Towards establishment of gene therapy for human pancreatic and endometrial cancers
建立人类胰腺癌和子宫内膜癌的基因疗法
- 批准号:
10557026 - 财政年份:1998
- 资助金额:
$ 8万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Identification of tumor suppressor genes in human pancreatic cancer
人胰腺癌抑癌基因的鉴定
- 批准号:
07457046 - 财政年份:1995
- 资助金额:
$ 8万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似海外基金
Investigation on naphthylisoquinoline alkaloids as potential antiausterity chemotherapy for pancreatic cancer
萘基异喹啉生物碱作为胰腺癌潜在抗紧缩化疗的研究
- 批准号:
23K26797 - 财政年份:2024
- 资助金额:
$ 8万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Proton radiation therapy combined with immunotherapy for enhancing antitumor immune responses in pancreatic cancer murine models.
质子放射治疗与免疫治疗相结合,增强胰腺癌小鼠模型的抗肿瘤免疫反应。
- 批准号:
24K10423 - 财政年份:2024
- 资助金额:
$ 8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A Conditionally Activable Small Molecule Pro-Drug Conjugate for Targeted Treatment of Pancreatic Cancer
用于胰腺癌靶向治疗的条件激活小分子前药偶联物
- 批准号:
EP/Y036336/1 - 财政年份:2024
- 资助金额:
$ 8万 - 项目类别:
Research Grant
Developing a Curative Therapy for Cancer Stroma Alterations in Pancreatic Cancer and Other Intractable Solid Tumors
开发针对胰腺癌和其他难治性实体瘤的癌症基质改变的治疗方法
- 批准号:
23H02868 - 财政年份:2023
- 资助金额:
$ 8万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Functional Analysis of Girdin in Anticancer Drug-Resistant Pancreatic Cancer and Its Application to Novel Therapeutic Agents
Girdin在抗癌药物耐药性胰腺癌中的功能分析及其在新型治疗药物中的应用
- 批准号:
23K08138 - 财政年份:2023
- 资助金额:
$ 8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Photoimmunotherapy for Novel Targets in Peritoneal metastasis of Pancreatic Cancer
光免疫疗法治疗胰腺癌腹膜转移的新靶点
- 批准号:
23K06753 - 财政年份:2023
- 资助金额:
$ 8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Nanobubbles for earlier pancreatic cancer detection
用于早期胰腺癌检测的纳米气泡
- 批准号:
2886053 - 财政年份:2023
- 资助金额:
$ 8万 - 项目类别:
Studentship
Exploring the molecular function of HIKESHI in pancreatic cancer tumor development and response to thermal/chemotherapy.
探索 HIKESHI 在胰腺癌肿瘤发展和热/化疗反应中的分子功能。
- 批准号:
23K14610 - 财政年份:2023
- 资助金额:
$ 8万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
New stool biomarker proteins for pancreatic cancer by the proteome analysis
通过蛋白质组分析发现胰腺癌的新粪便生物标志物蛋白
- 批准号:
23K14643 - 财政年份:2023
- 资助金额:
$ 8万 - 项目类别:
Grant-in-Aid for Early-Career Scientists














{{item.name}}会员




